Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine
- 15 December 1982
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 31 (24), 4089-4092
- https://doi.org/10.1016/0006-2952(82)90664-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effect of 6-azauracil, and of certain structurally similar compounds, on three pyridoxal-phosphate requiring enzymes involved in neurotransmitter metabolismBiochemical Pharmacology, 1979
- Catabolic degradation of 6-azauracil and 6-azauridine by Pseudomonas putidaCollection of Czechoslovak Chemical Communications, 1977
- Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetateBiochemical Pharmacology, 1973
- Hyperaminoacidemia in rabbits treated with 6-azauridine triacetateLife Sciences, 1971
- A simple enzymic assay for pyridoxal phosphateAnalytical Biochemistry, 1970
- Therapeutic effects of 6-azauridine-triacetate in psoriasisEuropean Journal of Clinical Pharmacology, 1970
- ‘Homocystinuria’ and urinary excretion of β-amino acids in patients treated with 6-azauridineClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Typical hyperaminoaciduria after high doses of 6-azauridine triacetateBiochemical Pharmacology, 1969
- Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis FungoidesAnnals of Internal Medicine, 1966
- Automatic Recording Apparatus for Use in Chromatography of Amino AcidsAnalytical Chemistry, 1958